Back to newsroom

Sophia Genetics partners with Microsoft to accelerate health data analysis

Tuesday 8 November 2022

The agreement between Sophia Genetics and Microsoft aims to expand and reinforce data-driven medicine through the SOPHiA DDM health data analysis platform available with Microsoft Azure. | © Sophia Genetics

Sophia Genetics, a Vaud-based cloud-native software company in the healthcare space, is embarking on a multi-year integrated strategic partnership with Microsoft to improve healthcare workflows globally.

This new partnership between Sophia Genetics and Microsoft will result in the development of next-generation healthcare solutions, which will lead the way in enabling multimodal curation, development, and deployment of data. As a result, the Microsoft Azure-powered SOPHiA DDM Platform is expected to elevate the standard of care for patients, by delivering advanced outcomes for precision medicine.

Headquartered in Lausanne (canton of Vaud), Sophia Genetics’ global network breaks down data silos, allowing the democratization of data-driven medicine by connecting institutions that leverage diverse multimodal data sets on the SOPHiA DDM Platform.

Multimodal health data sets can be the largest and most complex to structure, analyze and archive, and this wide-ranging partnership will focus on accelerating results, improving performance, and ultimately enhance medical research by propelling the transition to precision medicine globally.

Accelerating the transition to a decentralized model for the healthcare industry

“With Microsoft’s scale and the power of the SOPHiA DDM Platform, this partnership will help improve clinical outcomes and make patient care more efficient and personalized,” said Jurgi Camblong, Co-Founder and CEO of Sophia Genetics. “Sophia Genetics will help accelerate the transition to a decentralized care model for hospitals, healthcare providers and biopharma by breaking down data silos and delivering innovation at scale.”

A true success story from the heart of the Health Valley, this new strategic partnership further expands on Sophia Genetics’ and Microsoft’s existing collaboration. With the addition of the SOPHiA DDM Platform, providers utilizing Microsoft Azure will scale their ability to aggregate multimodal data types to extract insights within existing workflows for their pursuit to deliver the best care possible. As one of Microsoft’s chosen partners for precision medicine, Sophia Genetics will help accelerate the transition to a decentralized care model for hospitals, healthcare providers and biopharma, by breaking down data silos and delivering innovation at scale.

Partager sur Twitter Partager sur Facebook Partager sur Whatsapp Partager sur LinkedIn Partager par mail
Back to newsroom

This website uses cookies to improve user experience. More information